|
|
|
|
|
by 75dvtwin
1703 days ago
|
|
sorry, but your assessment of what is genuine vs disingenuous, is very disingenuous in itself. Perhaps, it is time to relinquish the presumptions of moral superiority -- and just discuss technical details without the drama ... I am saying that you wrote does not cover full spectrum of how the virus replicates, therefore your comment does illuminate the complexity that's present in interaction with our immune system.
Which includes, according to the NIH paper I referenced, antibody-dependent-enhancement (ADE). |
|
> However, using monkey and mouse models of SARS-CoV-2 infection, none of the in vitro infection-enhancing Abs enhanced SARS-CoV-2 virus replication or infectious virus in the lung in vivo. Three of 46 monkeys had lung pathology or bronchoalveolar lavage (BAL) cytokine levels greater than controls. However, repeat studies with dose ranges of in vitro enhancing Abs did not increase lung pathology. Thus, in vitro infection-enhancing RBD and NTD Abs controlled virus in vivo and was rarely associated with enhanced lung pathology. [1]
1: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232969/